BioResonator symptoms new orders for glaucoma diagnostic item distribution BioResonator signals new orders with several new distributors. By one month, the ongoing company gets the official CE approval necessary to sell their products through the entire European Union. The additional week we attended at the biggest European meeting for ophthalmologists in Paris, and received extremely positive response. The business has already signed agreements with distributors on a lot of its key marketplaces: THE UK, Spain, Italy, Holland and on the Scandinavian marketplaces Finland and Sweden.The expansion marks the company’s continued significant improvement in commercializing its proprietary technology, including mini-chromosomes which were developed at the originally University of Chicago by company CEO and co-founder Daphne Preuss. With the bigger workplace and laboratory space, the company will continue to increase its R&D actions which enable the development of new seed products and the delivery of multiple genetic characteristics in plants through gene-stacking, while widening their concentrate to pursue new applications, such as for example improved feedstocks targeting the bioenergy sector.